# SUPRAX
> **NDA202091** · New Drug Application · Sponsor: LUPIN LTD · Approved 2013-02-20
## Drug
- **FDA Application Number:** NDA202091
- **Application type:** New Drug Application
- **Brand name:** SUPRAX
- **Generic name:** Cefixime
- **Active ingredients:** CEFIXIME
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LUPIN LTD
- **First approval:** 2013-02-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202091)
---
*AI Analytics · CC0 1.0*